Pancreatic Cancer Research

ResearcherNara Medical UniversityNo recent work listed

Tadataka Takagi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9340-2775; OpenAlex author ID A5023184782. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 4 papers · 2022: none · 2023: 2 papers

Papers 7

  1. Importance of triple tumor markers as biomarkers in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ags3.12629↗
  2. Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms24087506↗
  3. A gene expression signature for predicting response to neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.33284↗
  4. Clinical relevance of CD70 expression in resected pancreatic cancer: Prognostic value and therapeutic potential. Co-author DOI 10.1016/j.pan.2021.01.013↗
  5. Does direct invasion of peripancreatic lymph nodes impact survival in patients with pancreatic ductal adenocarcinoma? A retrospective dual-center study. Co-author DOI 10.1016/j.pan.2021.03.008↗
  6. Is Neoadjuvant Treatment Justified in Clinical T1 Pancreatic Ductal Adenocarcinoma? Co-author DOI 10.3390/jcm10040873↗
  7. Significance of the inflammation-based prognostic score in recurrent pancreatic cancer. Co-author DOI 10.1016/j.pan.2019.05.461↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masayuki Sho · 7 shared papers, 2019–2023 · strength 0.93
  2. Minako Nagai · 5 shared papers, 2019–2023 · strength 0.63
  3. Kenji Nakagawa · 5 shared papers, 2019–2021 · strength 0.59
  4. Takahiro Akahori · 5 shared papers, 2019–2021 · strength 0.59
  5. Kota Nakamura · 4 shared papers, 2019–2021 · strength 0.47
  6. Satoshi Nishiwada · 3 shared papers, 2021–2023 · strength 0.43
  7. Taichi Terai · 3 shared papers, 2021–2023 · strength 0.42
  8. Naoya Ikeda · 3 shared papers, 2019–2021 · strength 0.33
  9. Yuichiro Kohara · 1 shared paper, 2023 · strength 0.18
  10. Satoshi Yasuda · 1 shared paper, 2023 · strength 0.18
  11. Hiroki Kuniyasu · 1 shared paper, 2023 · strength 0.16
  12. Joon Seong Park · 1 shared paper, 2021 · strength 0.14
  13. Hyung Sun Kim · 1 shared paper, 2021 · strength 0.14
  14. Dong Sup Yoon · 1 shared paper, 2021 · strength 0.14
  15. Wei Li · 1 shared paper, 2021 · strength 0.12
  16. Kensuke Yamamura · 1 shared paper, 2021 · strength 0.12
  17. Ajay Goel · 1 shared paper, 2021 · strength 0.12
  18. Hideo Baba · 1 shared paper, 2021 · strength 0.12
  19. So Yamaki · 1 shared paper, 2021 · strength 0.11
  20. Sohei Satoi · 1 shared paper, 2021 · strength 0.11
  21. Tatsuma Sakaguchi · 1 shared paper, 2021 · strength 0.11
  22. Hironori Ryota · 1 shared paper, 2021 · strength 0.11
  23. Daisuke Hashimoto · 1 shared paper, 2021 · strength 0.11
  24. Tomohisa Yamamoto · 1 shared paper, 2021 · strength 0.11
  25. Mitsugu Sekimoto · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.